In March 2019, the registration number of our company's medical low-density polyethylene film and bag is b20180001073. In the "publication of registration information of APIs, pharmaceutical excipients and drug packaging materials" of the drug review center of the State Drug Administration, "the result of joint review and approval with the preparation" is "a", which means that our company's product is a packaging material approved for use in the listed preparation.

Recently, Shanghai Haishun new pharmaceutical packaging materials Co., Ltd. (hereinafter referred to as Haishun new materials) has strategically invested in Shijiazhuang Zhonghui pharmaceutical packaging Co., Ltd. (hereinafter referred to as Zhonghui pharmaceutical packaging Co., Ltd.).

The cooperation between Zhonghui pharmaceutical and xinlitai pharmaceutical is exactly based on the excellent pursuit of pharmaceutical packaging and the concept of product excellence. Zhonghui pharmaceutical bag is an important supplier and strategic partner of xinlitai pharmaceutical. In 2018, both sides expressed their hope for in-depth cooperation.

Qilu pharmaceutical and Zhonghui pharmaceutical package are partners for many years. On April 18, 2018, four experts from Qilu pharmaceutical went to Zhonghui pharmaceutical package for on-site audit, aiming to strengthen the in-depth cooperation between the two sides, hoping to improve product quality and build a safety barrier for human health through the joint efforts of both sides.

On January 12, the official website of the national health and Family Planning Commission released the announcement on the priority evaluation of drug varieties to be recommended for major special projects of major new drug creation technology. According to the announcement, it is proposed to recommend 18 special supported drug varieties of Hengrui medicine (38.91, - 0.080, - 0.21%), Baiji Shenzhou, Institute of toxicants and drugs of the Academy of Military Medical Sciences, such as famitinib, bgb-283, and hydroxypiperone hydrochloride, as the priority evaluation varieties.